The Ark
A blog about our science, the rare disease community and PerlQuests
Our talk for the 2016 Grace Science Foundation Meeting
This past weekend was the 2016 Grace Science Foundation Meeting in Palo Alto. It was...
Introducing Perlara
Last month at the 5th annual Global Genes Patient Summit, we announced our rebrand...
A secondary assay for worms
We've not had a worm post in awhile, but that doesn't mean that worms (and we)...
New insights into targets for Niemann Pick C therapies through Drosophila genetics
Here I’ll sum up a recent paper in Developmental Cell by E. Thomas Danielson and...
Fruit Flies and DMSO Sensitivity
On my last blog I told you guys about a good friend of small drugs, DMSO who has...
From primary screen to mouse validation, Part 3
Last month I traveled to Tucson for my third consecutive Ara Parseghian Medical...
June in tweets
Summer is conference high season, and June was no exception. PLabbers fanned out...
A case for using model organisms in MLIV drug discovery
Last week I attended the 2016 Mucolipidosis Type IV (MLIV) conference in Atlanta. It...
May in tweets
YC Demo Day marked the beginning of Spring and a new chapter of growth for PLab. For...
Clinical relevance of a Drosophila model of Niemann-Pick C
Niemann-Pick type C (NPC) is a tragic childhood neurodegenerative disease. The...
A yeast model of cystic fibrosis
At PLab we're always on the lookout for new publications describing simple animal...
April in tweets
We kicked off April with Tamy's first post on the PLab blog. She and Tom have been...
